Cargando…

Seroprevalence of SARS-CoV-2–Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020

Close contacts of coronavirus disease (COVID-19) patients are at high risk for severe acute respiratory syndrome 2 (SARS-CoV-2) infection. We assessed the seroprevalence of SARS-CoV-2–specific antibodies among quarantined close contacts of COVID-19 patients in the Faroe Islands. We invited quarantin...

Descripción completa

Detalles Bibliográficos
Autores principales: Petersen, Maria Skaalum, Kristiansen, Marnar Fríðheim, Reinert, Halla Weihe, Fjallsbak, Jógvan Páll, Christiansen, Debes Hammershaimb, Gaini, Shahin, Steig, Bjarni á, Møller, Lars Fodgaard, Strøm, Marin, Weihe, Pál
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544982/
https://www.ncbi.nlm.nih.gov/pubmed/34437829
http://dx.doi.org/10.3201/eid2711.204948
_version_ 1784589930736910336
author Petersen, Maria Skaalum
Kristiansen, Marnar Fríðheim
Reinert, Halla Weihe
Fjallsbak, Jógvan Páll
Christiansen, Debes Hammershaimb
Gaini, Shahin
Steig, Bjarni á
Møller, Lars Fodgaard
Strøm, Marin
Weihe, Pál
author_facet Petersen, Maria Skaalum
Kristiansen, Marnar Fríðheim
Reinert, Halla Weihe
Fjallsbak, Jógvan Páll
Christiansen, Debes Hammershaimb
Gaini, Shahin
Steig, Bjarni á
Møller, Lars Fodgaard
Strøm, Marin
Weihe, Pál
author_sort Petersen, Maria Skaalum
collection PubMed
description Close contacts of coronavirus disease (COVID-19) patients are at high risk for severe acute respiratory syndrome 2 (SARS-CoV-2) infection. We assessed the seroprevalence of SARS-CoV-2–specific antibodies among quarantined close contacts of COVID-19 patients in the Faroe Islands. We invited quarantined close contacts of COVID-19 index patients identified during March 3–April 22, 2020, to participate in this study; 584 (81%) contacts consented and underwent serologic testing. Among the 584 participants, 32 (5.5%) were seropositive for total antibody against SARS-CoV-2. Household and young or elderly contacts had higher risk for seropositivity than other contacts. We found a secondary attack rate of 19.2%. Seroprevalence among close contacts was almost 10-fold higher than among the general population of the Faroe Islands. Regularly testing household close contacts of COVID-19 patients might help track the transmission of SARS-CoV-2.
format Online
Article
Text
id pubmed-8544982
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-85449822021-11-06 Seroprevalence of SARS-CoV-2–Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020 Petersen, Maria Skaalum Kristiansen, Marnar Fríðheim Reinert, Halla Weihe Fjallsbak, Jógvan Páll Christiansen, Debes Hammershaimb Gaini, Shahin Steig, Bjarni á Møller, Lars Fodgaard Strøm, Marin Weihe, Pál Emerg Infect Dis Research Close contacts of coronavirus disease (COVID-19) patients are at high risk for severe acute respiratory syndrome 2 (SARS-CoV-2) infection. We assessed the seroprevalence of SARS-CoV-2–specific antibodies among quarantined close contacts of COVID-19 patients in the Faroe Islands. We invited quarantined close contacts of COVID-19 index patients identified during March 3–April 22, 2020, to participate in this study; 584 (81%) contacts consented and underwent serologic testing. Among the 584 participants, 32 (5.5%) were seropositive for total antibody against SARS-CoV-2. Household and young or elderly contacts had higher risk for seropositivity than other contacts. We found a secondary attack rate of 19.2%. Seroprevalence among close contacts was almost 10-fold higher than among the general population of the Faroe Islands. Regularly testing household close contacts of COVID-19 patients might help track the transmission of SARS-CoV-2. Centers for Disease Control and Prevention 2021-11 /pmc/articles/PMC8544982/ /pubmed/34437829 http://dx.doi.org/10.3201/eid2711.204948 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Petersen, Maria Skaalum
Kristiansen, Marnar Fríðheim
Reinert, Halla Weihe
Fjallsbak, Jógvan Páll
Christiansen, Debes Hammershaimb
Gaini, Shahin
Steig, Bjarni á
Møller, Lars Fodgaard
Strøm, Marin
Weihe, Pál
Seroprevalence of SARS-CoV-2–Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020
title Seroprevalence of SARS-CoV-2–Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020
title_full Seroprevalence of SARS-CoV-2–Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020
title_fullStr Seroprevalence of SARS-CoV-2–Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020
title_full_unstemmed Seroprevalence of SARS-CoV-2–Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020
title_short Seroprevalence of SARS-CoV-2–Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020
title_sort seroprevalence of sars-cov-2–specific antibodies among quarantined close contacts of covid-19 patients, faroe islands, 2020
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544982/
https://www.ncbi.nlm.nih.gov/pubmed/34437829
http://dx.doi.org/10.3201/eid2711.204948
work_keys_str_mv AT petersenmariaskaalum seroprevalenceofsarscov2specificantibodiesamongquarantinedclosecontactsofcovid19patientsfaroeislands2020
AT kristiansenmarnarfriðheim seroprevalenceofsarscov2specificantibodiesamongquarantinedclosecontactsofcovid19patientsfaroeislands2020
AT reinerthallaweihe seroprevalenceofsarscov2specificantibodiesamongquarantinedclosecontactsofcovid19patientsfaroeislands2020
AT fjallsbakjogvanpall seroprevalenceofsarscov2specificantibodiesamongquarantinedclosecontactsofcovid19patientsfaroeislands2020
AT christiansendebeshammershaimb seroprevalenceofsarscov2specificantibodiesamongquarantinedclosecontactsofcovid19patientsfaroeislands2020
AT gainishahin seroprevalenceofsarscov2specificantibodiesamongquarantinedclosecontactsofcovid19patientsfaroeislands2020
AT steigbjarnia seroprevalenceofsarscov2specificantibodiesamongquarantinedclosecontactsofcovid19patientsfaroeislands2020
AT møllerlarsfodgaard seroprevalenceofsarscov2specificantibodiesamongquarantinedclosecontactsofcovid19patientsfaroeislands2020
AT strømmarin seroprevalenceofsarscov2specificantibodiesamongquarantinedclosecontactsofcovid19patientsfaroeislands2020
AT weihepal seroprevalenceofsarscov2specificantibodiesamongquarantinedclosecontactsofcovid19patientsfaroeislands2020